115 related articles for article (PubMed ID: 22727510)
21. Angiogenic targets for potential disorders.
Bhadada SV; Goyal BR; Patel MM
Fundam Clin Pharmacol; 2011 Feb; 25(1):29-47. PubMed ID: 20199582
[TBL] [Abstract][Full Text] [Related]
22. [Neoplasms and angiogenesis].
Lewy-Trenda I
Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
[TBL] [Abstract][Full Text] [Related]
23. Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival.
Shan S; Robson ND; Cao Y; Qiao T; Li CY; Kontos CD; Garcia-Blanco M; Dewhirst MW
FASEB J; 2004 Feb; 18(2):326-8. PubMed ID: 14688196
[TBL] [Abstract][Full Text] [Related]
24. Chaotic neovascularization induced by aggressive fibrosarcoma cells overexpressing S-adenosylmethionine decarboxylase.
Paasinen-Sohns A; Kääriäinen E; Yin M; Järvinen K; Nummela P; Hölttä E
Int J Biochem Cell Biol; 2011 Mar; 43(3):441-54. PubMed ID: 21134486
[TBL] [Abstract][Full Text] [Related]
25. Angiogenesis and its role in colorectal tumor and metastasis formation.
Ellis LM
Semin Oncol; 2004 Dec; 31(6 Suppl 17):3-9. PubMed ID: 15696024
[TBL] [Abstract][Full Text] [Related]
26. B-cell chronic lymphocytic leukemia: correlation of clinical stages with angiogenic cytokine expression.
Ho CL; Phyliky RL; Li CY
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):154-60. PubMed ID: 16785782
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in endometrial angiogenesis research.
Girling JE; Rogers PA
Angiogenesis; 2005; 8(2):89-99. PubMed ID: 16211359
[TBL] [Abstract][Full Text] [Related]
28. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
Go RS; Jobe DA; Asp KE; Callister SM; Mathiason MA; Meyer LA; Bottner WA; Cole CE; Farnen JP; Frisby KA
Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423
[TBL] [Abstract][Full Text] [Related]
29. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
[TBL] [Abstract][Full Text] [Related]
30. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
[TBL] [Abstract][Full Text] [Related]
31. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
Bremnes RM; Camps C; Sirera R
Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
[TBL] [Abstract][Full Text] [Related]
32. [Angiogenesis in different clinical phases of chronic myeloid leukemia].
Krasowska-Kwiecień A; Kijowski J; Łukasiewicz E; Sacha T; Foryciarz K; Majka M; Ratajczak MZ; Skotnicki AB
Przegl Lek; 2009; 66(9):471-8. PubMed ID: 21033405
[TBL] [Abstract][Full Text] [Related]
33. Angiopoietin-2 overexpression in morris hepatoma results in increased tumor perfusion and induction of critical angiogenesis-promoting genes.
Kunz P; Hoffend J; Altmann A; Dimitrakopoulou-Strauss A; Koczan D; Eisenhut M; Bonaterra GA; Dengler TJ; Mier W; Haberkorn U; Kinscherf R
J Nucl Med; 2006 Sep; 47(9):1515-24. PubMed ID: 16954561
[TBL] [Abstract][Full Text] [Related]
34. Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways.
Mirshahi P; Toprak SK; Faussat AM; Dubrulle S; Marie JP; Soria C; Soria J; Mirshahi M
Biochem Biophys Res Commun; 2006 Oct; 349(3):1003-10. PubMed ID: 16959214
[TBL] [Abstract][Full Text] [Related]
35. Bioinorganic aspects of angiogenesis.
D'Andrea LD; Romanelli A; Di Stasi R; Pedone C
Dalton Trans; 2010 Sep; 39(33):7625-36. PubMed ID: 20535417
[TBL] [Abstract][Full Text] [Related]
36. Angiogenesis in acute and chronic lymphocytic leukemia.
Molica S; Vacca A; Levato D; Merchionne F; Ribatti D
Leuk Res; 2004 Apr; 28(4):321-4. PubMed ID: 15109528
[TBL] [Abstract][Full Text] [Related]
37. Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL).
Aguayo A; Manshouri T; O'Brien S; Keating M; Beran M; Koller C; Kantarjian H; Rogers A; Albitar M
Leuk Res; 2001 Apr; 25(4):279-85. PubMed ID: 11248324
[TBL] [Abstract][Full Text] [Related]
38. Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia.
Kini AR; Kay NE; Peterson LC
Leukemia; 2000 Aug; 14(8):1414-8. PubMed ID: 10942237
[TBL] [Abstract][Full Text] [Related]
39. Angiogenesis in B-cell chronic lymphocytic leukemia: methods of study, clinical significance and prognostic implications.
Molica S
Leuk Lymphoma; 2001 Aug; 42(4):603-7. PubMed ID: 11697488
[TBL] [Abstract][Full Text] [Related]
40. Heparan sulfate in angiogenesis: a target for therapy.
van Wijk XM; van Kuppevelt TH
Angiogenesis; 2014 Jul; 17(3):443-62. PubMed ID: 24146040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
